Clinical validation of colorectal cancer biomarkers identified from bioinformatics analysis of public expression data

Clinical Cancer Research

Volumn 17, Issue 4, 2011, Pages 700-709

  Jung, Yeonjoo ^a   Lee, Sanghyuk ^a,b   Choi, Hyung Seok ^a   Kim, Soon Nam ^a   Lee, Eunyoung ^a   Shin, Youngah ^a   Seo, Jihae ^a   Kim, Bumjin ^a   Jung, Yeonhwa ^a   Kim, Wan Kyu ^a   Chun, Ho Kyung ^c   Lee, Woo Yong ^c   Kim, Jaesang ^a  

^a Ewha Womans University   (South Korea)

^b Korean Bioinformation Center   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTYLGLUTAMYLALANYLASPARTIC ACID BOX POLYPEPTIDE 21; BIOLOGICAL MARKER; CHAPERONIN; CHROMOSOME 9 OPEN READING FRAME 140; CYCLIN DEPENDENT KINASE 2; EPITHELIAL CELL TRANSFORMING SEQUENCE 2 ONCOPROTEIN; ETS VARIANT GENE 4; ONCOPROTEIN; RAN PROTEIN; RIBOSOMAL PROTEIN S4X; RNA; S100 CALCIUM BINDING PROTEIN A11; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; CANCER INVASION; CANCER STAGING; CANCER TISSUE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; MARKER GENE; ONCOGENE C MYC; ONCOGENE K RAS; PRIORITY JOURNAL; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UPREGULATION; VALIDATION STUDY;

ADENOVIRUS E1A PROTEINS; ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; DEAD-BOX RNA HELICASES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; PROTO-ONCOGENE PROTEINS P21(RAS); RIBOSOMAL PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 79951833554     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-10-1300     Document Type: Article

References (34)

1. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008;134:1570-95.
2. Goh KL. Changing trends in gastrointestinal disease in the Asia-Pacific region. J Dig Dis 2007;8:179-85.
3. Yee YK, Tan VP, Chan P, Hung IF, Pang R, Wong BC. Epidemiology of colorectal cancer in Asia. J Gastroenterol Hepatol 2009;24:1810-6.
4. Sienel W, Dango S, Ehrhardt P, Eggeling S, Kirschbaum A, Passlick B. The future in diagnosis and staging of lung cancer. Molecular techniques. Respiration 2006;73:575-80. (Pubitemid 44481470)
5. Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I, Kerr D. Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 2009;9:489-99.
6. Nannini M, Pantaleo MA, Maleddu A, Astolfi A, Formica S, Biasco G. Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives. Cancer Treat Rev 2009;35:201-9.
7. Petty RD, Nicolson MC, Kerr KM, Collie-Duguid E, Murray GI. Gene expression profiling in non-small cell lung cancer: from molecular mechanisms to clinical application. Clin Cancer Res 2004;10:3237-48. (Pubitemid 38685427)
8. Cardoso J, Boer J, Morreau H, Fodde R. Expression and genomic profiling of colorectal cancer. Biochim Biophys Acta 2007;1775:103-37. (Pubitemid 44881195)
9. Kim B, Lee HJ, Choi HY, Shin Y, Nam S, Seo G, et al. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data. Cancer Res 2007;67:7431-8. (Pubitemid 47206573)
10. Lee Y, Lee Y, Kim B, Shin Y, Nam S, Kim P, et al. ECgene: an alternative splicing database update. Nucleic Acids Res 2007;35:D99-103.
11. Graudens E, Boulanger V, Mollard C, Mariage-Samson R, Barlet X, Gremy G, et al. Deciphering cellular states of innate tumor drug responses. Genome Biol 2006;7:R19.
12. Alon U, Barkai N, Notterman DA, Gish K, Ybarra S, Mack D, et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci USA 1999;96:6745-50. (Pubitemid 29274954)
13. Zou TT, Selaru FM, Xu Y, Shustova V, Yin J, Mori Y, et al. Application of cDNA microarrays to generate a molecular taxonomy capable of distinguishing between colon cancer and normal colon. Oncogene 2002;21:4855-62. (Pubitemid 34879462)
14. Notterman DA, Alon U, Sierk AJ, Levine AJ. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 2001;61:3124-30. (Pubitemid 32691964)
15. Zhu K, Henning D, Valdez B, Busch H. Human RNA helicase II/Gu gene: genomic organization and promoter analysis. Biochem Biophys Res Commun 2001;281:1006-11. (Pubitemid 32917832)
16. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. Identification of c-MYC as a target of the APC pathway. Science 1998;281:1509-12. (Pubitemid 28425575)
17. Yeh JJ, Routh ED, Rubinas T, Peacock J, Martin TD, Shen XJ, et al. KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer. Mol Cancer Ther 2009;8:834-43.
18. Cappello F, de Macario EC, Marasa L, Zummo G, Macario AJ. Hsp60 expression, new locations, functions and perspectives for cancer diagnosis and therapy. Cancer Biol Ther 2008;7:801-9.
19. Horiuchi S, Yamamoto H, Min Y, Adachi Y, Itoh F, Imai K. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer. J Pathol 2003;200:568-76. (Pubitemid 36987305)
20. Li M, Lin YM, Hasegawa S, Shimokawa T, Murata K, Kameyama M, et al. Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray. Int J Oncol 2004;24:305-12.
21. Lin HM, Chatterjee A, Lin YH, Anjomshoaa A, Fukuzawa R, McCall JL, et al. Genome wide expression profiling identifies genes associated with colorectal liver metastasis. Oncol Rep 2007;17:1541-9.
22. Azuma K, Sasada T, Takedatsu H, Shomura H, Koga M, Maeda Y, et al. Ran, a small GTPase gene, encodes cytotoxic T lymphocyte (CTL) epitopes capable of inducing HLA-A33-restricted and tumor-reactive CTLs in cancer patients. Clin Cancer Res 2004;10:6695-702. (Pubitemid 39346567)
23. Rensen WM, Mangiacasale R, Ciciarello M, Lavia P. The GTPase Ran: regulation of cell life and potential roles in cell transformation. Front Biosci 2008;13:4097-121. (Pubitemid 351611596)
24. He H, Li J, Weng S, Li M, Yu Y. S100A11: diverse function and pathology corresponding to different target proteins. Cell Biochem Biophys 2009;55:117-26.
25. Miki T, Smith CL, Long JE, Eva A, Fleming TP. Oncogene ect2 is related to regulators of small GTP-binding proteins. Nature 1993;362:462-5. (Pubitemid 23107372)
26. Saito S, Liu XF, Kamijo K, Raziuddin R, Tatsumoto T, Okamoto I, et al. Deregulation and mislocalization of the cytokinesis regulator ECT2 activate the Rho signaling pathways leading to malignant transformation. J Biol Chem 2004;279:7169-79. (Pubitemid 38248864)
27. Hirata D, Yamabuki T, Miki D, Ito T, Tsuchiya E, Fujita M, et al. Involvement of epithelial cell transforming sequence-2 oncoantigen in lung and esophageal cancer progression. Clin Cancer Res 2009;15:256-66.
28. Sano M, Genkai N, Yajima N, Tsuchiya N, Homma J, Tanaka R, et al. Expression level of ECT2 proto-oncogene correlates with prognosis in glioma patients. Oncol Rep 2006;16:1093-8.
29. Cimino D, Fuso L, Sfiligoi C, Biglia N, Ponzone R, Maggiorotto F, et al. Identification of new genes associated with breast cancer progression by gene expression analysis of predefined sets of neoplastic tissues. Int J Cancer 2008;123:1327-38.
30. Xu X, Li W, Fan X, Liang Y, Zhao M, Zhang J, et al. Identification and characterization of a novel p42.3 gene as tumor-specific and mitosis phase-dependent expression in gastric cancer. Oncogene 2007;26:7371-9. (Pubitemid 350115973)
31. Hakuma N, Kinoshita I, Shimizu Y, Yamazaki K, Yoshida K, Nishimura M, et al. E1AF/PEA3 activates the Rho/Rho-associated kinase pathway to increase the malignancy potential of non-small-cell lung cancer cells. Cancer Res 2005;65:10776-82. (Pubitemid 41713346)
32. Kaya M, Yoshida K, Higashino F, Mitaka T, Ishii S, Fujinaga K. A single ets-related transcription factor, E1AF, confers invasive phenotype on human cancer cells. Oncogene 1996;12:221-7. (Pubitemid 26042559)
33. Plesec TP, Hunt JL. KRAS mutation testing in colorectal cancer. Adv Anat Pathol 2009;16:196-203.
34. Di Nicolantonio F, Martini M, Molinari F, Sartore-Bianchi A, Arena S, Saletti P, et al. Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer. J Clin Oncol 2008;26:5705-12.